Politics and Government Politics and Government
Wed, November 27, 2024
Tue, November 26, 2024
[ Tue, Nov 26th 2024 ] - Brian Stokes
Trust Matters in Cabinet Picks
Mon, November 25, 2024
Sun, November 24, 2024
Thu, November 14, 2024
Tue, November 12, 2024
Thu, April 23, 2009
Mon, February 2, 2009
[ Mon, Feb 02nd 2009 ] - Nathan Burkes
Is Obama a rock star?
Fri, January 30, 2009

Geron Announces Conference Call to Discuss Financial Results for the 2010 Third Quarter


Published on 2010-10-25 13:40:38 - Market Wire
  Print publication without navigation


MENLO PARK, Calif.--([ BUSINESS WIRE ])--Geron Corporation (Nasdaq:GERN) will announce its financial results for the 2010 third quarter on Thursday, October 28, 2010, after the closing of the equity market. Thomas B. Okarma, Ph.D., M.D., Gerona�s president and chief executive officer, and David L. Greenwood, Gerona�s executive vice president and chief financial officer, will host a conference call for analysts and investors on Friday, October 29, 2010 at 8:00 a.m. Pacific Time, 11:00 a.m. Eastern Time.

Participants can access the conference call live via telephone by dialing 866-730-5770 (U.S.); 857-350-1594 (international). The passcode is 14864744. A live audio-only webcast is also available through a link that is posted on the Events page in the Investor Relations section of Gerona�s Web site at [ http://www.geron.com ]. The audio Web broadcast of the conference call will be available for replay within 60 minutes following the live broadcast through November 29, 2010.

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit [ www.geron.com ].


Publication Contributing Sources